Stock Scorer
Stock Board CompareNew Screen
Donate
…
Report Measures Companies Earnings calendar
Sign in

Novo Nordisk A/S (NOVO-B.CO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in DKK. Every figure as a table ›

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 150B 300B 450B FY22: 177B FY23: 232.3B FY24: 290.4B FY25: 309.1B FY22 FY23 FY24 FY25

Gross Profit Annual

0 90B 180B 270B FY22: 148.5B FY23: 196.5B FY24: 245.9B FY25: 250.3B FY22 FY23 FY24 FY25

Operating Income Annual

0 50B 100B 150B FY22: 74.8B FY23: 102.6B FY24: 128.3B FY25: 127.7B FY22 FY23 FY24 FY25

Net Income Annual

0 35B 70B 105B FY22: 55.5B FY23: 83.7B FY24: 101B FY25: 102.4B FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 20B 40B 60B FY22: 28.4B FY23: 35.8B FY24: 44.5B FY25: 58.8B FY22 FY23 FY24 FY25

Operating Cash Flow Annual

0 50B 100B 150B FY22: 78.9B FY23: 108.9B FY24: 121B FY25: 119.1B FY22 FY23 FY24 FY25

Free Cash Flow Annual

0 30B 60B 90B FY22: 66.7B FY23: 83.1B FY24: 73.8B FY25: 59B FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 2B 4B 6B FY23: 4.5B FY24: 4.5B FY25: 4.5B FY26: 4.4B FY23 FY24 FY25 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS Annual

0.00 8.00 16.00 24.00 FY22: 12.22 FY23: 18.62 FY24: 22.63 FY25: 23.03 FY22 FY23 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.